8-K: Enhabit Secures Multi-Year Agreement with UnitedHealthcare and Provides 2025 Pricing Update

Enhabit, Inc. has reached a new multi-year agreement with UnitedHealthcare, ensuring continued access for UHC members to Enhabit's home health services, and provided an update on anticipated pricing impacts for 2025.

Summary

• Enhabit, Inc. has finalized a new multi-year agreement with UnitedHealthcare, effective January 1, 2025, ensuring continued access to Enhabit's home health services for UHC members.
• The company will participate in the BofA Securities 2024 Home Care Conference on December 10, 2024, where they will discuss strategic focus and recent business developments.
• Enhabit anticipates a $19-21 million revenue increase in 2025 due to pricing adjustments.
• This includes an estimated $11-13 million from the 2025 final rule on Fee for Service Medicare, Non-Medicare Episodic, and improved Medicare Advantage contracted pricing.
• An additional $8 million is expected from the annual Medicare pricing update for consolidated hospice.

Sentiment

Score: 7

Explanation: The document presents a positive outlook with a new agreement and expected revenue growth, but also includes standard risk disclosures, resulting in a moderately positive sentiment.

Positives

• The new multi-year agreement with UnitedHealthcare provides stability and continued access to a large patient base.
• The anticipated revenue increase of $19-21 million in 2025 from pricing adjustments is a positive financial development.
• Projected midto high-single digit growth in both home health admissions and hospice volumes over the next three years indicates strong future potential.
• The company is actively working to improve clinical capacity and payor contracts to support growth.

Risks

• The document includes a standard disclaimer about forward-looking statements, highlighting that actual results may differ due to various factors.
• These factors include regulatory changes, reimbursement rates, economic conditions, and the company's ability to manage costs and retain personnel.
• The company's performance is subject to risks related to information system disruptions, litigation, and the integration of new locations and acquisitions.

Future Outlook

Enhabit anticipates continued growth in home health admissions and hospice volumes at midto high-single digits over the next three years, supported by improved clinical capacity and payor contracts. The company expects a revenue increase in 2025 due to pricing adjustments.

Management Comments

• Enhabit's President and Chief Executive Officer, Barbara Jacobsmeyer, along with incoming Chief Financial Officer, Ryan Solomon, and SVP of Strategic Finance & Treasurer, Jobie Williams, will participate in a fireside chat to discuss the company's strategic focus and recent business developments.
• Management intends to discuss an update to anticipated pricing impacts for 2025 at the conference.

Industry Context

The agreement with UnitedHealthcare is significant as it ensures continued access to a major payor network, which is crucial for home health and hospice providers. The pricing update reflects the ongoing adjustments in the healthcare reimbursement landscape, particularly with Medicare and Medicare Advantage programs. The focus on growth in admissions and volumes aligns with the industry trend of increasing demand for home-based care.

Comparison to Industry Standards

• The projected midto high-single digit growth in home health and hospice volumes is in line with industry expectations for the sector, which is experiencing increased demand due to an aging population and a preference for home-based care.
• Companies like LHC Group and Amedisys, which are also major players in the home health and hospice space, have reported similar growth trends in recent years.
• The estimated revenue increase from pricing adjustments is a common occurrence in the healthcare industry, as providers negotiate rates with payors and adapt to regulatory changes.
• The specific impact of the 2025 final rule on Medicare reimbursement is a key factor for all home health providers, and Enhabit's estimated $11-13 million impact is a significant data point for comparison.

Stakeholder Impact

• Shareholders can expect positive impacts from the new agreement and anticipated revenue growth.
• Patients will continue to have access to Enhabit's home health services through UnitedHealthcare.
• Employees may benefit from the company's growth and stability.

Next Steps

• Enhabit will participate in the BofA Securities 2024 Home Care Conference on December 10, 2024.
• The new agreement with UnitedHealthcare will go into effect on January 1, 2025.

Key Dates

Keywords

home health, hospice, UnitedHealthcare, pricing, revenue, Medicare, admissions, growth, BofA Securities, healthcare